Imagio® Breast Imaging System

Breast biopsy procedures caused by false-positive diagnostic assessments in the US cost the healthcare system more than $2 billion per year. Imagio® could mitigate that by providing real-time information regarding suspicious breast masses and increased decision confidence regarding the need for invasive breast biopsies and additional exams.

i-STAT Alinity TBI Plasma Test

The i-STAT Alinity TBI Plasma Test is the first rapid, handheld blood test for concussions that uses brain-specific biomarkers to help physicians objectively evaluate the need for a head CT scan. Unnecessary CT scans for mild traumatic brain injuries may be reduced by up to 40%, which minimizes radiation exposure and shortens hospital wait times.

Portable Edge AI-DR

The Portable Edge AI-DR is the world’s first AI-assisted system to be integrated into a handheld fundus camera to detect diabetic retinopathy (DR). The system can accurately identify four main DR lesions and classify five severity levels, assisting physicians in early diagnosis of DR. This will benefit people who need diabetes care in remote areas.

Access Vascular hydrophilic catheters

Roughly 90% of all admitted hospital patients receive a venous access device, 30% of those will experience complications (including clots & infection). AVI’s groundbreaking hydrophilic catheters mimic the body’s chemistry to evade its natural defenses and nearly eliminate these common & costly complications for better medical and economic outcomes.

BioMS-Ti

BioMS-Ti is a hybrid bionic skeleton structure that allows integration of hard and soft tissue. The bio-active cannulated implant has a controllable porous structure design and can be combined with bio-ceramic or osteogenic materials, improving bone regeneration and tissue integration for personalized medical implants.

Tria™ Ureteral Stents

Urine calcium and magnesium salt deposits are contributing factors to stent complications such as encrustation. In vitro BEST method studies of the Tria™ stent demonstrate a reduction in the combined urine calcium and magnesium salt deposits, both in the presence and absence of bacteria.

CELLACON Platform

Cell reprogramming platform technology is an innovative cell therapy technology that converts cells into therapeutic cells within 15 days as a direct cell cross-differentiation (Cella X) technology based on low molecular weight compounds (drug cocktail composed of 5-10 drugs with low molecular weight, which is cheaper, like aspirin)

iTind™

The iTind™, a temporarily implanted nitinol device, is placed in the prostatic urethra in a folded configuration. The super-elastic nitinol struts exert ischemic pressure at the 12, 5, and 7 o’clock positions, reshaping the tissue to allow urine to flow. After 5 to 7 days, the device is completely removed, and patients experience immediate relief.

LEOTEK Ecological Conservation Smart Lighting

Have you ever seen swarms of tropical pedicel ants around LED streetlights? Climate change and urbanization disrupt mating behaviors of pedicel ants a lot. The innovation of LED streetlights with the ‘patented optical front masks’ designed to maintain ecological balance by effectively filtering out blue spectrum that is the most attractive to them.

VITROS® Anti-SARS-CoV-2 IgG Quantitative Test

Ortho’s quantitative COVID-19 IgG test helps labs accurately measure the level of COVID-19 antibodies in a patient sample and is the first standardized quantitative test to receive US FDA EUA. This test provides a standardized tool to help the health care community understand the long-term impacts of the COVID-19 pandemic.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report